Defending Consultants

Your article "Science for Sale" (November 28, 1988, page 1) suffered from the very symptoms that the author, Bruce Stutz, attributes to his subjects, "biostitutes." To begin with, my firm was incorrectly characterized as "also doing public relations work for the incinerator industry." We work for citizens advisory groups, public officials, and developers in evaluating or preparing environmental impact statements of projects of all kinds. Like the museum scientist quoted, our clients know we

Written byCarolyn Konheim
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Your article "Science for Sale" (November 28, 1988, page 1) suffered from the very symptoms that the author, Bruce Stutz, attributes to his subjects, "biostitutes."

To begin with, my firm was incorrectly characterized as "also doing public relations work for the incinerator industry." We work for citizens advisory groups, public officials, and developers in evaluating or preparing environmental impact statements of projects of all kinds. Like the museum scientist quoted, our clients know we "don't turn tricks."

It is absurd to distrust the science because a consultant authored an article in a professional journal. A good journal subjects all articles to equally rigorous peer review. The reason consultants often make important contributions to knowledge is that they are retained to solve problems. In doing so, they're often on the cutting edge of what is known and have to develop tools and solutions quickly. It is not that academic scientists are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies